Am J Psychiatry 159:738-745, May 2002
© 2002 American Psychiatric Association
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer’s Disease Treatment Studies
Gene E. Alexander, Ph.D.,
Kewei Chen, Ph.D.,
Pietro Pietrini, M.D., Ph.D.,
Stanley I. Rapoport, M.D., and
Eric M. Reiman, M.D.
OBJECTIVE: It is well established that regional cerebral metabolic rates for glucose assessed by [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with Alzheimer’s disease in the mental resting state (eyes and ears covered) provide a sensitive, in vivo metabolic index of Alzheimer’s disease dementia. Few studies, however, have evaluated longitudinal declines in regional cerebral glucose metabolism in patients with dementia caused by Alzheimer’s disease. In addition, the available studies have not used recently developed brain mapping algorithms to characterize the progression of Alzheimer’s disease throughout the brain, and none considered the statistical power of regional cerebral glucose metabolism in testing the ability of treatments to attenuate the progression of dementia. METHOD: The authors used FDG PET and a brain mapping algorithm to investigate cross-sectional reductions in regional cerebral glucose metabolism, longitudinal decline in regional cerebral glucose metabolism after a 1-year follow-up, and the power of this method to evaluate treatments for Alzheimer’s disease in patients with mild to moderate dementia. PET scans were initially acquired in 14 patients with Alzheimer’s disease and 34 healthy comparison subjects of similar age and sex. Repeat scans were obtained in the patients 1 year later. Power analyses for voxels showing maximal decline over the 1-year period in regional cerebral glucose metabolism (mg/100 g per minute) were computed to estimate the sample sizes needed to detect a significant treatment response in a 1-year, double-blind, placebo-controlled treatment study. RESULTS: The patients with Alzheimer’s disease had significantly lower glucose metabolism than healthy comparison subjects in parietal, temporal, occipital, frontal, and posterior cingulate cortices. One year later, the patients with Alzheimer’s disease had significant declines in glucose metabolism in parietal, temporal, frontal, and posterior cingulate cortices. Using maximal glucose metabolism reductions in the left frontal cortex, we estimated that as few as 36 patients per group would be needed to detect a 33% treatment response with one-tailed significance of p 0.005 and 80% power in a 1-year, double-blind, placebo-controlled treatment study. CONCLUSIONS: These findings indicate that brain metabolism as assessed by FDG PET during mental rest is a sensitive marker of disease progression in Alzheimer’s disease over a 1-year period. These findings also support the feasibility of using FDG PET as an outcome measure to test the ability of treatments to attenuate the progression of Alzheimer’s disease.
This article has been cited by other articles:
|
|
|
|
 
W. S. Liang, E. M. Reiman, J. Valla, T. Dunckley, T. G. Beach, A. Grover, T. L. Niedzielko, L. E. Schneider, D. Mastroeni, R. Caselli, et al.
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
PNAS,
March 18, 2008;
105(11):
4441 - 4446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Alexander, K. Chen, M. Aschenbrenner, T. L. Merkley, L. E. Santerre-Lemmon, J. L. Shamy, W. E. Skaggs, M. H. Buonocore, P. R. Rapp, and C. A. Barnes
Age-Related Regional Network of Magnetic Resonance Imaging Gray Matter in the Rhesus Macaque
J. Neurosci.,
March 12, 2008;
28(11):
2710 - 2718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Deng, B. Li, F. Liu, K. Iqbal, I. Grundke-Iqbal, R. Brandt, and C.-X. Gong
Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease
FASEB J,
January 1, 2008;
22(1):
138 - 145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R I SCAHILL and N C FOX
Longitudinal imaging in dementia
Br. J. Radiol.,
December 1, 2007;
80(Special_Issue_2):
S92 - S98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K HERHOLZ, S F CARTER, and M JONES
Positron emission tomography imaging in dementia
Br. J. Radiol.,
December 1, 2007;
80(Special_Issue_2):
S160 - S167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Johnson, M. L. Ries, T. M. Hess, C. M. Carlsson, C. E. Gleason, A. L. Alexander, H. A. Rowley, S. Asthana, and M. A. Sager
Effect of Alzheimer Disease Risk on Brain Function During Self-appraisal in Healthy Middle-aged Adults
Arch Gen Psychiatry,
October 1, 2007;
64(10):
1163 - 1171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chen, E. M. Reiman, G. E. Alexander, R. J. Caselli, R. Gerkin, D. Bandy, A. Domb, D. Osborne, N. Fox, W. R. Crum, et al.
Correlations Between Apolipoprotein E {epsilon}4 Gene Dose and Whole Brain Atrophy Rates
Am J Psychiatry,
June 1, 2007;
164(6):
916 - 921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. W. Bokde, P. Lopez-Bayo, T. Meindl, S. Pechler, C. Born, F. Faltraco, S. J. Teipel, H.-J. Moller, and H. Hampel
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment
Brain,
May 1, 2006;
129(5):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lind, J. Persson, M. Ingvar, A. Larsson, M. Cruts, C. Van Broeckhoven, R. Adolfsson, L. Backman, L.-G. Nilsson, K. M. Petersson, et al.
Reduced functional brain activity response in cognitively intact apolipoprotein E {varepsilon}4 carriers
Brain,
May 1, 2006;
129(5):
1240 - 1248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Reiman, K. Chen, G. E. Alexander, R. J. Caselli, D. Bandy, D. Osborne, A. M. Saunders, and J. Hardy
From The Cover: Correlations between apolipoprotein E {epsilon}4 gene dose and brain-imaging measurements of regional hypometabolism
PNAS,
June 7, 2005;
102(23):
8299 - 8302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Helguera, A. Pelsman, G. Pigino, E. Wolvetang, E. Head, and J. Busciglio
ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons
J. Neurosci.,
March 2, 2005;
25(9):
2295 - 2303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Mosconi, D. Perani, S. Sorbi, K. Herholz, B. Nacmias, V. Holthoff, E. Salmon, J.-C. Baron, M. T.R. De Cristofaro, A. Padovani, et al.
MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
Neurology,
December 28, 2004;
63(12):
2332 - 2340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wells, L. K. Kreppel, F. I. Comer, B. E. Wadzinski, and G. W. Hart
O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits
J. Biol. Chem.,
September 10, 2004;
279(37):
38466 - 38470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Teipel, G. E. Alexander, M. B. Schapiro, H.-J. Moller, S. I. Rapoport, and H. Hampel
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Brain,
April 1, 2004;
127(4):
811 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Reiman, K. Chen, G. E. Alexander, R. J. Caselli, D. Bandy, D. Osborne, A. M. Saunders, and J. Hardy
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
PNAS,
January 6, 2004;
101(1):
284 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Haier, M. T. Alkire, N. S. White, M. R. Uncapher, E. Head, I. T. Lott, and C. W. Cotman
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Neurology,
December 23, 2003;
61(12):
1673 - 1679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Matthews, E. R. Siemers, and P. D. Mozley
Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease
Am J Geriatr Psychiatry,
April 1, 2003;
11(2):
146 - 159.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
